<DOC>
	<DOCNO>NCT03014700</DOCNO>
	<brief_summary>One common hemostatic derangement pediatric open- heart surgery acute acquire hypofibrinogenemia . This compromise fibrin clot generation platelet aggregation , result increase bleed allogenic blood transfusion . Currently , fresh frozen plasma cryoprecipitate use supplement fibrinogen pediatric cardiac patient . We propose replace cryoprecipitate fibrinogen concentrate effective treat post-CPB bleeding decrease total blood product exposure use part blood transfusion algorithm . We plan include patient undergoing cardiac surgery CPB le 12 month fibrinogen level &lt; 250mg/dL bypass . We hope demonstrate fibrinogen concentrate least effective standard care management peri- operative bleeding neonatal patient undergo cardiopulmonary bypass . If able demonstrate fibrinogen least effective standard care , would plan multi-center trial demonstrate safety efficacy medication . If able demonstrate fibrinogen concentrate effective , fibrinogen concentrate could replace allogenic product potentially decrease transfusion relate morbidity mortality population .</brief_summary>
	<brief_title>Fibrinogen Concentrate v Cryoprecipitate</brief_title>
	<detailed_description>Patients 12 month age require cardiopulmonary bypass surgery approach study . Patients pre- exist coagulopathy , include unexplained bleed history clotting , exclude . Prior study beginning , patient randomize standard transfusion algorithm cryoprecipitate fibrinogen concentrate . As standard care , laboratory test send standard time point 1. induction anesthesia , 2. initiation bypass , 3. separation bypass administration protamine , 4. arrival ICU . These laboratory test include hematocrit , arterial blood gas , chemistry , thromboelastogram ( TEG ) fibrinogen . Additional laboratory test send indicated clinical scenario determine transfusion requirement . For patient enrol study , standardize anesthetic management , cardiopulmonary bypass protocol , transfusion threshold operate room ICU . We collect demographic data , intraop post-op laboratory value , bypass time , intraop post op transfusion data , chest tube output , adverse event , length ventilation , ICU stay hospital stay . For patient randomize study arm ( fibrinogen concentrate ) , fibrinogen level measure bypass use calculate appropriate dose fibrinogen concentrate achieve level 300mg/dL separation bypass . Fibrinogen concentrate replace cryoprecipitate post-operative transfusion algorithm . If patient continue bleed base laboratory value clinical situation , patient give cryoprecipitate rescue measure . Patients study protocol receive normal transfusion algorithm .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<criteria>Neonates least 32 week gestational age infant 12 month age diagnosis congenital heart disease , require open heart surgery cardiopulmonary bypass Preexisting coagulopathy , include unexplained bleed history clotting</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>